RE:A couple months ago...Good post bud...agreeable 100%. I will just add that once Onc put in place the stipulation that any acquirer/licensee would have to make a deal for all indications & that they would refuse to package them separately, this made the additions of the Parsons and Rigby an absolutel necessity. These negotiations will be protracted with a lot of money involved. The business end of a biotech is not Coffey's forte...he & the BOD recognizing this gave me great confidence. GL all.